Live-cell quantitative monitoring reveals distinct, high-affinity Gβγ regulations of GIRK2 and GIRK1/2 channels
G<sub>i/o</sub> protein-coupled receptors (GPCRs) inhibit cardiac and neuronal excitability via G protein-activated K<sup>+</sup> channels (GIRK), assembled by combinations of GIRK1 - GIRK4 subunits. GIRKs are activated by direct binding of the Gβγ dimer of inhibitory G<sub>i/o</sub> proteins. However, key aspects of this textbook signaling pathway remain debated. Recent studies suggested no G<sub>i/o</sub>-GIRK pre-coupling and low (>250 µM) Gβγ-GIRK interaction affinity, contradicting earlier sub-µM estimates and implying low signaling efficiency. We show that Gγ prenylation, which mediates Gβγ membrane attachment required for GIRK activation, also contributes to the Gβγ-GIRK interaction, explaining the poor affinity obtained with non-prenylated Gβγ. Using quantitative protein titration and electrophysiology in live Xenopus oocytes, Gβγ affinity for homotetrameric GIRK2 ranges from 4-30 µM. Heterotetrameric GIRK1/2 shows a higher Gβγ apparent affinity due to the Gβγ-docking site (anchor) in GIRK1, which enriches Gβγ at the channel. Biochemical approaches and molecular dynamic simulations reveal that the Gβγ anchor is formed by interacting N-terminal and distal C-terminal domains of the GIRK1 subunits, distinct from the Gβγ-binding "activation" site(s) underlying channel opening. Thus, the affinity of Gβγ-GIRK interaction is within the expected physiological range, while dynamic pre-coupling of Gβγ to GIRK1-containing channels through high-affinity interactions further enhances the GPCR-G<sub>i/o</sub>-GIRK signaling efficiency.
Authors
- Anna Stary‐Weinzinger (ORCID: https://orcid.org/0000-0002-9202-0484)
- Vladimir Tsemakhovich (ORCID: https://orcid.org/0000-0002-4969-6497)
- Debi Ranjan Tripathy (ORCID: https://orcid.org/0000-0002-6842-0138)
- Uri Kahanovitch (ORCID: https://orcid.org/0000-0002-6203-7103)
- Reem Handklo‐Jamal (ORCID: https://orcid.org/0000-0001-6237-5412)
- Daniel Yakubovich (ORCID: https://orcid.org/0000-0003-2871-1026)
- Tal Keren‐Raifman
- Boris Shalomov (ORCID: https://orcid.org/0000-0002-1322-4906)
- Carmen Dessauer (ORCID: https://orcid.org/0000-0003-1210-4280)
- Joel A. Hirsch (ORCID: https://orcid.org/0000-0001-7544-8668)
- Enno Klußmann (ORCID: https://orcid.org/0000-0003-4004-5003)
- Nathan Dascal (ORCID: https://orcid.org/0000-0002-5397-4146)
- Galit Tabak (ORCID: https://orcid.org/0000-0003-0414-0847)
- Theres Friesacher (ORCID: https://orcid.org/0000-0001-5632-3472)
- Yoni Haitin (ORCID: https://orcid.org/0000-0002-1648-6792)
- Kerstin Zühlke
- Orna Chomsky-Hecht (ORCID: https://orcid.org/0000-0001-7329-9785)
- Haritha P. Reddy (ORCID: https://orcid.org/0000-0002-6280-6558)
- Patrick Hofer (ORCID: https://orcid.org/0009-0004-5778-9599)
Institutions
- University of Copenhagen (DK)
- University of Vienna (AT)
- Tel Aviv University (IL)
- Max Delbrück Center (DE)
- German Centre for Cardiovascular Research (DE)
- The University of Texas Health Science Center (US)
- Ariel University (IL)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1038/s41467-025-66730-8
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Austrian Science Fund
- National Institutes of Health